# Study of Single-dose DS-3201b in Participants With Hepatic Impairment

> **NCT04276662** · PHASE1 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 28 (actual)

## Conditions studied

- Hepatic Impairment

## Interventions

- **DRUG:** DS-3201b

## Key facts

- **NCT ID:** NCT04276662
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-21
- **Primary completion:** 2021-02-23
- **Final completion:** 2021-02-23
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2021-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04276662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04276662, "Study of Single-dose DS-3201b in Participants With Hepatic Impairment". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04276662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*